Findings

What do systematic reviews say?

30 questions · 40 findings · 4 reviews · Gut

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 15%GRADE not reported 0 · 0%Very low 26 · 65%Low 7 · 17.5%Moderate 1 · 2.5%High 0 · 0%

Physical activity advice plus placebo vs no physical activity advice plus omega 3

Fatigue · participants with quiescent IBD

4 findings from 1 review

Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 29 participants
Very low
Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 29 participants
Very low
Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 29 participants
Very low

Show 1 more finding

Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 29 participants
Very low

Physical activity advice plus placebo vs no physical activity advice plus omega 3

Adverse events: · participants with quiescent IBD

1 finding from 1 review

Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 29 participants
Very low

Physical activity advice plus placebo vs no physical activity advice plus omega 3

Serious adverse events ‐ not reported · participants with quiescent IBD

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Physical activity advice plus placebo vs no physical activity advice plus omega 3

Withdrawals due to adverse events ‐ not reported · participants with quiescent IBD

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for fatigue in inflammatory bowel disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient education and standard care vs usual care

Disease activity · people with inflammatory bowel disease

1 finding from 1 review

Patient education interventions for the management of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 479 participants
Moderate

Web‐based patient education vs other delivery of patient education

Disease activity · people with inflammatory bowel disease

1 finding from 1 review

Patient education interventions for the management of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Very low

Weekly educational texts messages vs once every other week educational text messages

Disease activity · people with inflammatory bowel disease

1 finding from 1 review

Patient education interventions for the management of inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 131 participants
Very low

Oral ferric maltol vs IV ferric carboxymaltose

Number of responders ‐ disease activity not stated (12 weeks) · IBD patients

Oral ferric maltol showed no clear difference in number of responders ‐ disease activity not stated (12 weeks) compared with IV ferric carboxymaltose (low certainty).

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
RR 0.83 [0.65, 1.06]
1 study · 252 participants
Low

IM erythropoietin + IV iron sucrose vs IV iron sucrose + IM placebo

Number of responders ‐ disease activity not stated (12 weeks) · IBD patients

IM erythropoietin + IV iron sucrose showed no clear difference in number of responders ‐ disease activity not stated (12 weeks) compared with IV iron sucrose + IM placebo (low certainty).

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
RR 1.2 [0.9, 1.61]
1 study · 40 participants
Low

IM erythropoietin + IV iron sucrose vs IV iron sucrose + IM placebo

Serious adverse events ‐ disease activity not stated (12 weeks) · IBD patients

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low